Delivering mRNA Therapeutics to the Pancreas
Researchers at Carnegie Mellon University are one step closer to unlocking the potential of gene therapeutics to treat incurable pancreatic diseases, as they’ve created technology that delivers to a very important organ. The team’s aim is to improve delivery systems by changing the chemistry of the nanoparticles to reroute them in the body. Watch this video to learn how this research may lead to new treatments for type 1 diabetes and certain types of pancreatic cancer.
"This unexpected delivery to the islets would enable treatments for several very serious conditions, including Type 1 diabetes and a type of pancreatic cancer that originates within these islets," said Kathryn Whitehead , a professor of chemical engineering and biomedical engineering at Carnegie Mellon University.